Diuretics -Loop Products Step Therapy Policy
Defines a step therapy program for selected loop diuretics administered under Cigna benefit plans, specifying Step 1 preferred products and Step 2 products that require prior trial of a Step 1 product for coverage; approvals are for 1 year.
Annual Revision indicated 'No criteria changes' for reviews dated 06/14/2023, 06/26/2024, and 06/18/2025.
Coverage Summary
Defines a step therapy program for selected loop diuretics administered under Cigna benefit plans, specifying Step 1 preferred products and Step 2 products that require prior trial of a Step 1 product for coverage; approvals are for 1 year. Coverage stance: covered_with_criteria — Step 2 products are covered when step therapy criteria are met (patient has tried one Step 1 product).
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.